The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cholera Vaccine (Oral Route)-Global Market Insights and Sales Trends 2025
Synopsis
The global Cholera Vaccine (Oral Route) market size is expected to reach US$ 1525.6 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Cholera Vaccine (Oral Route) in various end use industries. The expanding demands from the Hospital, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies and Others, are propelling Cholera Vaccine (Oral Route) market. Shanchol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dukoral segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cholera Vaccine (Oral Route), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cholera Vaccine (Oral Route) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cholera Vaccine (Oral Route) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cholera Vaccine (Oral Route) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cholera Vaccine (Oral Route) covered in this report include PaxVax, Sanofi, Valneva and EuBiologics, etc.
The global Cholera Vaccine (Oral Route) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
PaxVax
Sanofi
Valneva
EuBiologics
Global Cholera Vaccine (Oral Route) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cholera Vaccine (Oral Route) market, Segment by Type:
Shanchol
Dukoral
Vaxchora
Others
Global Cholera Vaccine (Oral Route) market, by Application
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Cholera Vaccine (Oral Route) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Cholera Vaccine (Oral Route) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Cholera Vaccine (Oral Route) market size is expected to reach US$ 1525.6 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Cholera Vaccine (Oral Route) in various end use industries. The expanding demands from the Hospital, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies and Others, are propelling Cholera Vaccine (Oral Route) market. Shanchol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dukoral segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cholera Vaccine (Oral Route), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cholera Vaccine (Oral Route) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cholera Vaccine (Oral Route) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cholera Vaccine (Oral Route) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cholera Vaccine (Oral Route) covered in this report include PaxVax, Sanofi, Valneva and EuBiologics, etc.
The global Cholera Vaccine (Oral Route) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
PaxVax
Sanofi
Valneva
EuBiologics
Global Cholera Vaccine (Oral Route) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cholera Vaccine (Oral Route) market, Segment by Type:
Shanchol
Dukoral
Vaxchora
Others
Global Cholera Vaccine (Oral Route) market, by Application
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Cholera Vaccine (Oral Route) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Cholera Vaccine (Oral Route) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Cholera Vaccine (Oral Route) Market Overview
1.1 Cholera Vaccine (Oral Route) Product Overview
1.2 Cholera Vaccine (Oral Route) Market Segment by Type
1.2.1 Shanchol
1.2.2 Dukoral
1.2.3 Vaxchora
1.2.4 Others
1.3 Global Cholera Vaccine (Oral Route) Market Size by Type
1.3.1 Global Cholera Vaccine (Oral Route) Market Size Overview by Type (2018-2029)
1.3.2 Global Cholera Vaccine (Oral Route) Historic Market Size Review by Type (2018-2023)
1.3.3 Global Cholera Vaccine (Oral Route) Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cholera Vaccine (Oral Route) Sales Breakdown by Type (2018-2023)
1.4.2 Europe Cholera Vaccine (Oral Route) Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Cholera Vaccine (Oral Route) Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Cholera Vaccine (Oral Route) Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Cholera Vaccine (Oral Route) Sales Breakdown by Type (2018-2023)
2 Global Cholera Vaccine (Oral Route) Market Competition by Company
2.1 Global Top Players by Cholera Vaccine (Oral Route) Sales (2018-2023)
2.2 Global Top Players by Cholera Vaccine (Oral Route) Revenue (2018-2023)
2.3 Global Top Players by Cholera Vaccine (Oral Route) Price (2018-2023)
2.4 Global Top Manufacturers Cholera Vaccine (Oral Route) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cholera Vaccine (Oral Route) Market Competitive Situation and Trends
2.5.1 Cholera Vaccine (Oral Route) Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Cholera Vaccine (Oral Route) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cholera Vaccine (Oral Route) as of 2022)
2.7 Date of Key Manufacturers Enter into Cholera Vaccine (Oral Route) Market
2.8 Key Manufacturers Cholera Vaccine (Oral Route) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cholera Vaccine (Oral Route) Status and Outlook by Region
3.1 Global Cholera Vaccine (Oral Route) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Cholera Vaccine (Oral Route) Historic Market Size by Region
3.2.1 Global Cholera Vaccine (Oral Route) Sales in Volume by Region (2018-2023)
3.2.2 Global Cholera Vaccine (Oral Route) Sales in Value by Region (2018-2023)
3.2.3 Global Cholera Vaccine (Oral Route) Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Cholera Vaccine (Oral Route) Forecasted Market Size by Region
3.3.1 Global Cholera Vaccine (Oral Route) Sales in Volume by Region (2024-2029)
3.3.2 Global Cholera Vaccine (Oral Route) Sales in Value by Region (2024-2029)
3.3.3 Global Cholera Vaccine (Oral Route) Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Cholera Vaccine (Oral Route) by Application
4.1 Cholera Vaccine (Oral Route) Market Segment by Application
4.1.1 Hospital
4.1.2 Research & Academic Laboratories
4.1.3 Pharmaceutical & Biotechnology Companies
4.1.4 Others
4.2 Global Cholera Vaccine (Oral Route) Market Size by Application
4.2.1 Global Cholera Vaccine (Oral Route) Market Size Overview by Application (2018-2029)
4.2.2 Global Cholera Vaccine (Oral Route) Historic Market Size Review by Application (2018-2023)
4.2.3 Global Cholera Vaccine (Oral Route) Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cholera Vaccine (Oral Route) Sales Breakdown by Application (2018-2023)
4.3.2 Europe Cholera Vaccine (Oral Route) Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Cholera Vaccine (Oral Route) Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Cholera Vaccine (Oral Route) Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Cholera Vaccine (Oral Route) Sales Breakdown by Application (2018-2023)
5 North America Cholera Vaccine (Oral Route) by Country
5.1 North America Cholera Vaccine (Oral Route) Historic Market Size by Country
5.1.1 North America Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Cholera Vaccine (Oral Route) Sales in Volume by Country (2018-2023)
5.1.3 North America Cholera Vaccine (Oral Route) Sales in Value by Country (2018-2023)
5.2 North America Cholera Vaccine (Oral Route) Forecasted Market Size by Country
5.2.1 North America Cholera Vaccine (Oral Route) Sales in Volume by Country (2024-2029)
5.2.2 North America Cholera Vaccine (Oral Route) Sales in Value by Country (2024-2029)
6 Europe Cholera Vaccine (Oral Route) by Country
6.1 Europe Cholera Vaccine (Oral Route) Historic Market Size by Country
6.1.1 Europe Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Cholera Vaccine (Oral Route) Sales in Volume by Country (2018-2023)
6.1.3 Europe Cholera Vaccine (Oral Route) Sales in Value by Country (2018-2023)
6.2 Europe Cholera Vaccine (Oral Route) Forecasted Market Size by Country
6.2.1 Europe Cholera Vaccine (Oral Route) Sales in Volume by Country (2024-2029)
6.2.2 Europe Cholera Vaccine (Oral Route) Sales in Value by Country (2024-2029)
7 Asia-Pacific Cholera Vaccine (Oral Route) by Region
7.1 Asia-Pacific Cholera Vaccine (Oral Route) Historic Market Size by Region
7.1.1 Asia-Pacific Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Cholera Vaccine (Oral Route) Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Cholera Vaccine (Oral Route) Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Cholera Vaccine (Oral Route) Forecasted Market Size by Region
7.2.1 Asia-Pacific Cholera Vaccine (Oral Route) Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Cholera Vaccine (Oral Route) Sales in Value by Region (2024-2029)
8 Latin America Cholera Vaccine (Oral Route) by Country
8.1 Latin America Cholera Vaccine (Oral Route) Historic Market Size by Country
8.1.1 Latin America Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Cholera Vaccine (Oral Route) Sales in Volume by Country (2018-2023)
8.1.3 Latin America Cholera Vaccine (Oral Route) Sales in Value by Country (2018-2023)
8.2 Latin America Cholera Vaccine (Oral Route) Forecasted Market Size by Country
8.2.1 Latin America Cholera Vaccine (Oral Route) Sales in Volume by Country (2024-2029)
8.2.2 Latin America Cholera Vaccine (Oral Route) Sales in Value by Country (2024-2029)
9 Middle East and Africa Cholera Vaccine (Oral Route) by Country
9.1 Middle East and Africa Cholera Vaccine (Oral Route) Historic Market Size by Country
9.1.1 Middle East and Africa Cholera Vaccine (Oral Route) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Cholera Vaccine (Oral Route) Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Cholera Vaccine (Oral Route) Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Cholera Vaccine (Oral Route) Forecasted Market Size by Country
9.2.1 Middle East and Africa Cholera Vaccine (Oral Route) Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Cholera Vaccine (Oral Route) Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 PaxVax
10.1.1 PaxVax Company Information
10.1.2 PaxVax Introduction and Business Overview
10.1.3 PaxVax Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2018-2023)
10.1.4 PaxVax Cholera Vaccine (Oral Route) Products Offered
10.1.5 PaxVax Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Cholera Vaccine (Oral Route) Products Offered
10.2.5 Sanofi Recent Development
10.3 Valneva
10.3.1 Valneva Company Information
10.3.2 Valneva Introduction and Business Overview
10.3.3 Valneva Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Valneva Cholera Vaccine (Oral Route) Products Offered
10.3.5 Valneva Recent Development
10.4 EuBiologics
10.4.1 EuBiologics Company Information
10.4.2 EuBiologics Introduction and Business Overview
10.4.3 EuBiologics Cholera Vaccine (Oral Route) Sales, Revenue and Gross Margin (2018-2023)
10.4.4 EuBiologics Cholera Vaccine (Oral Route) Products Offered
10.4.5 EuBiologics Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cholera Vaccine (Oral Route) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cholera Vaccine (Oral Route) Industrial Chain Analysis
11.4 Cholera Vaccine (Oral Route) Market Dynamics
11.4.1 Cholera Vaccine (Oral Route) Industry Trends
11.4.2 Cholera Vaccine (Oral Route) Market Drivers
11.4.3 Cholera Vaccine (Oral Route) Market Challenges
11.4.4 Cholera Vaccine (Oral Route) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cholera Vaccine (Oral Route) Distributors
12.3 Cholera Vaccine (Oral Route) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
